On this UVA Speaks podcast, Joshua Mauldin and Matthew Rannals of the UVA Licensing & Ventures Group (LVG) explain the work done by the technology transfer office. Listen in to hear how the group assists in managing the intellectual property that comes out of research conducted by UVA faculty, staff, and students through the development of patents and licenses. We also hear about the LVG Seed Fund that supports new ventures emerging in the UVA research portfolio. This fund can bridge the gap between basic research funding from places like the National Institutes for Health (NIH) to keep the study viable until an investor can be found to develop the marketplace opportunities. Transcripts of the audio broadcast can be found at https://engagement.virginia.edu/sites/default/files/2021-10/LL%20PC%20captions%20maudlin%2C%20rannals.pdf Joshua Mauldin is a Licensing Manager working predominately with technologies in biomedical science and chemistry and is responsible for evaluating the patentability and marketability of assets created from UVA research. He holds a Ph.D. in Cell Biology from the University of Virginia. He works with UVA’s departments of Biology, Biomedical Sciences, Chemistry, Medicine, Physics, Statistics, and the Beirne B. Carter Center for Immunology Research. Matthew Rannals is a Venture Associate in UVA’s Licensing & Ventures Group. Matt joined UVA in January 2020 and is responsible for identifying new ventures within the University portfolio, working alongside the licensing team, and contributing to the success of the Seed Fund. Matthew holds a Ph.D. in Neuroscience from the University of Virginia and has held research fellowships at Johns Hopkins University, Penn State University, and the University of Pittsburgh.

Ver todos los episodios